Ad
ARDX - Ardelyx Stock Trading
About | Ardelyx Inc. (NASDAQ:ARDX)
Not available
Quote | Ardelyx Inc. (NASDAQ:ARDX)
| Last: | $4.04 |
|---|---|
| Change Percent: | -0.24% |
| Open: | $4.15 |
| Close: | $4.04 |
| High: | $4.19 |
| Low: | $3.99 |
| Volume: | 3,239,693 |
| Last Trade Date Time: | 09/28/2023 03:00:00 am |
News | Ardelyx Inc. (NASDAQ:ARDX)
-
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
-
Ardelyx ( NASDAQ: ARDX ) stated Thursday it has signed a financing deal with HealthCare Royalty Partners to receive up to $20M on the the sale of its future royalties and sales milestones from Kyowa Kirin. Kyowa Kirin is Ardelyx' collaboration partner in Japan fo...
Message Board Posts | Ardelyx Inc. (NASDAQ:ARDX)
| Subject | By | Source | When |
|---|---|---|---|
| $ARDX Are we heading down to the daily | TripTrap | investorshub | 04/28/2023 2:08:33 PM |
| 1 year chart. You don't even need | Cosa | investorshub | 04/27/2023 9:07:48 PM |
| Benny $ARDX is a BP buyout candidate like | Whalatane | investorshub | 04/22/2023 10:16:59 PM |
| Agree. It looks fabulous! Would | Cosa | investorshub | 04/19/2023 8:28:20 PM |
| If an offering occurs after approval and is, | Benny450 | investorshub | 04/19/2023 4:55:57 PM |
Ad
-
ARDX - Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference | Benzinga
WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, ...
-
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
-
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...